British pharma major AstraZeneca (LSE: AZN) has joined a near-$100 million series A and A+ financing round for Syneron Bio, a ...

Danish biotech Sidera Bio has raised about 700 million Kroner ($109 million) in a series A financing, one of the largest ...

New York, USA-based rare disease firm Applied Therapeutics has announced a definitive agreement to be acquired by ...

A major European pharmacy meeting that combines a professional congress with a large exhibition focused on medicines and ...

The US Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for the use of an oral pellet ...

Medra, a US company developing the first platform for physical AI scientists, has announced a $52 million Series A financing.

US late-stage rare disease focused pharma Rezolute announced disappointing top-line results from its Phase III sunRIZE study ...

Eli Lilly has shown the strength of its obesity pipeline beyond its on-market blockbuster Mounjaro (tirzepatide) ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...

California, USA-based biotech Prolynx, which is developing a next-generation portfolio of ultra-long-acting medicines for ...

Irish pharma manufacturer Gaelic Laboratories has acquired Athlone Laboratories, another Irish producer focused on oral dose ...